鹏华中证医药指数(LOF)C(010366)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-7,369,458.70 |
7,258,127.80 |
3,662,840.55 |
-14,779,901.10 |
| 利息合计 |
10,819.40 |
24,876.73 |
12,358.58 |
26,336.51 |
| 其中:存款利息收入 |
10,819.40 |
24,876.73 |
12,358.58 |
26,336.51 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-4,788,661.89 |
-7,564,819.03 |
-5,064,168.78 |
-10,033,208.06 |
| 其中:股票投资收益 |
-5,805,786.45 |
-9,248,734.22 |
-6,097,543.42 |
-12,118,490.05 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
1,017,124.56 |
1,683,915.19 |
1,033,374.64 |
2,085,281.99 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-2,618,806.13 |
14,722,715.20 |
8,668,973.39 |
-4,849,349.20 |
| 其他收入 |
27,189.92 |
75,354.90 |
45,677.36 |
76,319.65 |
| 费用 |
521,180.68 |
1,179,581.71 |
588,604.51 |
1,386,145.60 |
| 管理人报酬 |
362,832.75 |
833,734.86 |
414,049.39 |
842,188.52 |
| 基金托管费 |
72,566.59 |
166,746.93 |
82,809.81 |
168,437.75 |
| 销售服务费 |
12,743.71 |
26,644.17 |
13,908.20 |
28,013.46 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
73,037.63 |
152,455.75 |
77,837.11 |
347,505.87 |
| 利润总额 |
-7,890,639.38 |
6,078,546.09 |
3,074,236.04 |
-16,166,046.70 |